Purchase Order 75N93021P01355
Award Date 9/17/21
Potential Completion Date 9/19/22
Potential Value $898K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions, to provide a NEXTSEQ 2000 SEQUENCING SYSTEM in support of COVID-19 research. The $338,350.00 contract has a completion date of September 25, 2020 and was awarded on June 22, 2020 with no set-aside designation. Illumina has previously provided sequencing...
- The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $340,025 firm fixed price purchase order to Illumina, Inc. to deliver one NextSEQ2000 genome sequencer to the Laboratory of Parasitic Diseases. The sequencer will support the laboratory's SARS-CoV-2 and other research efforts. As the prime contractor, Illumina will furnish the requested high-throughput sequencer from its San Diego, California location by the end date of October 25, 2021 to meet...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed price purchase order to Illumina, Inc. for a NextSeq 2000 sequencing system to support COVID-19 research. The $341,700.00 award did not have a set-aside designation. Illumina is a manufacturer of genomic sequencing instruments and reagents that has received prior federal contract awards from agencies such as the National Institutes of Health,...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS - NIH) awarded a $1.9 million firm fixed price purchase order to Illumina, Inc. for an ILLUMINA NOVASEQ X PLUS SEQUENCING SYSTEM. The contract will be performed in Bethesda, Maryland and runs from May 11, 2023 through May 10, 2024. The NovaSeq X Plus Sequencing System from Illumina is a high-throughput DNA sequencing platform capable of generating over 1.8 trillion...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $341,700.00 firm fixed price purchase order to Illumina, Inc. for the NEXTSEQ 2000 SEQUENCING SYSTEM in support of COVID-19 response efforts. The award was made on August 17, 2020 with a completion date of December 31, 2020. Illumina is a manufacturer and provider of sequencing and array-based genomic analysis solutions, and has a history of providing...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $289,275 firm-fixed price purchase order to Illumina, Inc. of San Diego, California. The contract is for one NEXTSEQ 2000 SEQUENCING SYSTEM to support ongoing COVID-19 and infectious disease research. Delivery is required by January 31, 2023 in Bethesda, Maryland per the original solicitation seeking offers for the Illumina NextSeq-2000 sequencing system and...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a firm fixed price delivery order to Illumina, Inc., a for-profit manufacturer of genomic sequencing systems and reagents, for the provision of Illumina's NovaSeq reagent kits. The $107,866.08 contract supports COVID-19 research and has a completion date of May 7, 2024. Illumina has previously held prime federal contracts with agencies such as the...
- The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $1.98 million firm fixed price delivery order to Illumina, Inc. under an unidentified multiple award contract vehicle. The order is for reagents, kits, and library preparation supplies from Illumina to support COVID-19 research and sequencing efforts. Specifically, Illumina will provide 172 NovaSeq 6000 S4 reagent kits, four Nextera DNA Flex library preparation kits, four IDT for Illumina...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $207,415 firm fixed price purchase order to Illumina, Inc. of San Diego, California. Under the terms of the contract, Illumina will provide one NEXTSEQ 2000 sequencing system to support NIH's research efforts in the areas of allergy and infectious disease. Place of performance is Illumina's facilities in San Diego. The period of performance is from...
- The Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases awarded a $953,700.00 firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer, to provide a NOVASEQ 6000 sequencing system. The contract has no set-aside designation and was completed on September 29, 2017. Illumina has previously received prime contracts from various federal agencies, including the NIH, CDC, USDA, and VA, to supply...